Insulet Corporation’s cover photo
Insulet Corporation

Insulet Corporation

Medical Equipment Manufacturing

Acton, Massachusetts 135,784 followers

About us

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Omnipod products are offered in 25 countries around the globe. HIRING SCAM ALERT Recently, individuals impersonating Insulet Human Resources members have offered fraudulent interviews and job offers to unsuspecting candidates. To help protect you from these scam artists, please be aware that: • Insulet will never interview a candidate over RingCentral, similar messaging apps or social media (i.e. Google Hangouts, WhatsApp, Facebook Messenger, etc.), or via text message. • Insulet will never send a company check or ask an applicant to pay a fee or purchase at home work/training materials in connection with an application for employment. • Insulet will never provide excess money to an applicant and ask the applicant to write a check for repayment. If you have any doubt about a job offer or any other communication purporting to come from Insulet, please reach out to us directly at 978-600-7000. If you receive any type of communication on behalf of Insulet that seems inappropriate or suspicious, please report this activity to: www.iC3.gov or www.stopfraud.gov.

Website
http://www.insulet.com/
Industry
Medical Equipment Manufacturing
Company size
1,001-5,000 employees
Headquarters
Acton, Massachusetts
Type
Public Company
Specialties
Medical Devices, Diabetic Management, Biotechnology, Medical Supply, Advanced Manufacturing, and Medical Supply Chain

Locations

Employees at Insulet Corporation

Updates

  • The insights that fuel our innovation start with the providers caring for our Podders every day! President & CEO Ashley McEvoy recently joined Territory Manager Dmitry Krasnopolsky in the field, sitting down with endocrinologists to hear firsthand how they're navigating diabetes care. Understanding the challenges and opportunities HCPs face every day isn't just valuable, it's essential to how we innovate for our customers. As Dmitry shared, "Having such an impactful leader in medtech connect directly with endocrinologists in the territory was truly inspiring! The future of diabetes care is incredibly bright, and moments like this reinforce the innovation and progress ahead to simplify lives.” #TeamInsulet

    • No alternative text description for this image
  • We’re excited to welcome Mike Panos as Insulet’s new EVP & Chief Commercial Officer.   Mike brings 30 years of commercial leadership experience in the medical technology sector. Over his career at Stryker, he built and scaled high-performing teams, led global businesses, and consistently delivered strong growth in highly competitive markets. He is known for developing exceptional talent, instilling rigor and accountability, and driving execution at scale.   At Insulet, Mike will lead our global commercial organization, with responsibility for advancing commercial strategy and execution across markets, expanding access to Omnipod®, and helping more people living with diabetes benefit from automated insulin delivery.   Mike will play a key role as we continue to build on our strong foundation and scale our impact globally. Learn more: https://lnkd.in/eJwDU8mx   Please join us in welcoming Mike to the Insulet team!   #Leadership #Growth #Innovation #Insulet #DiabetesCare

    • No alternative text description for this image
  • Giving back to the diabetes community is at the heart of who we are at Insulet. One hundred members of our U.S. sales team gathered recently in Dallas to pack 440 hero-themed care kits for the Message of Hope Foundation, in support of Children's Health Dallas and children with diabetes. Each bag was filled with activities and games designed to bring a little joy to children in hospitals and shelters. This is just one step toward our Company's goal of 5,000 collective volunteer hours in 2025, as part of our Insulet for Good initiative. We're proud of every employee who showed up and gave their time to make a difference. #TeamInsulet

    • No alternative text description for this image
  • More than two decades of partnership with NXP Semiconductors and counting! What began as a supplier relationship has grown into a trusted collaboration that continues to help Insulet drive innovation in diabetes management. A special thank you to Jason O'Connor, Vice President, Next Generation Platforms, for sharing his perspective on what this partnership means to our Company. Learn more: https://lnkd.in/eBQ6djNr

    View organization page for NXP Semiconductors

    938,495 followers

    Making life better for people with diabetes, together. For 20+ years, we’ve been a trusted technology partner for Insulet Corporation's Omnipod® platform, a wearable insulin pump that helps automate diabetes management. Insulet brings deep diabetes expertise. We bring the secure edge technology inside the system. Together, we’re making insulin delivery more trusted and intelligent. It’s a step forward for the future of innovative healthcare. Discover the collaboration story: https://okt.to/pTaLS4 #BrighterTogether #StepForward

    • No alternative text description for this image
  • Recording podcasts at events like ATTD allows Insulet to capture the knowledge of the world's leading experts in Automated Insulin Delivery, right where the most important conversations in diabetes care are happening. Show after show, our team sits down with the brightest minds in the field to bring Healthcare Professionals the latest advances, insights, and clinical perspectives across our three podcasts: Within Range, TypeCast, and Beyond the Bolus. A huge thank you to our incredible team and partners who build a studio on the show floor, record, edit, and bring these episodes to life. Your dedication and hard work is what makes these conversations possible. Subscribe now so you don't miss the new episodes: 🎙️ Within Range: https://lnkd.in/ecnSTuDX q48m 🎙️ Typecast: https://lnkd.in/ecBYxW_s 🎙️ Beyond the Bolus resources/podcast: https://lnkd.in/eQ_4mgba #ATTD26 #TeamInsulet

  • Our commitment to strengthening communities and improving the lives of people with diabetes is at the heart of Insulet for Good, our global giving program. We work to expand access to diabetes education, care, and technology while supporting organizations that make measurable impacts. Through volunteer opportunities, matching gifts, and community engagement, we empower employees to support meaningful causes and help us build stronger, healthier communities, together. We’re proud that this commitment has earned Insulet recognition as one of America’s Most Charitable Companies 2026, an acknowledgment to the generosity, service, and passion our teams bring every day. Learn more: https://lnkd.in/efNFA_Bd   #TeamInsulet

    • No alternative text description for this image
    • No alternative text description for this image
  • National Hockey League players push their bodies to the limit—speed, strength, agility, and split‑second decision‑making are non‑negotiable. For athletes with type 1 diabetes (T1D), the stakes are even higher. Glucose control directly affects performance, recovery, and reaction time. Few know this better than Max Domi, NHL player, Breakthrough T1D Canada | Percée DT1 ambassador, and proud Podder®. Diagnosed at 12, his first question was, “Can I still play hockey?” Nearly 20 years later, he’s not just playing—he’s thriving and leading by example for the T1D community. We’re excited to announce our partnership with Max as he teams up with Insulet Canada to share how Omnipod® 5 helps make diabetes management the simple part of an intense, fast‑paced life. While every shift on the ice demands total focus, Omnipod 5 helps him stay locked in on what matters most: the game. Our “Game Changing Simplicity” campaign features Max in a brand spot, photoshoot, and testimonial video, highlighting how Omnipod empowers people with diabetes to excel—on and off the ice. Visit the YouTube Canada channel to check out the brand spot: https://lnkd.in/eci7Eny3 A huge thank you to the Insulet Canada marketing team for bringing this to life! #TeamInsulet

    • No alternative text description for this image
  • The Commercial Operations team in Sydney kicked off 2026 with a team building challenge that mixed charity, creativity, and plenty of laughs.  Split into three competitive teams, they battled it out in charades, word scrambles, and even Play-Doh sculpting before tackling the main event, building tricycles for the DANII Foundation, a charity supporting people with type 1 diabetes. Each team capped off the fun by crafting a spirited sales pitch on why their bike reigned supreme. In the end, there was healthy competition, lots of smiles, and three brand new bicycles.  As part of our ongoing Insulet for Good initiative, the event was a fantastic chance to strengthen their teamwork while giving back to the type 1 diabetes community at the same time. #TeamInsulet

    • No alternative text description for this image
  • We’re thrilled to announce that Insulet’s CES exhibit has been recognized with a Bronze BOSS (Best of Show Stand) Award, placing 11th out of more than 4,100 exhibitors at CES 2026. This recognition is an especially significant achievement as it marks our Company’s first showing at CES. The BOSS Awards, presented by The Experiential Design Authority, honor exhibits that deliver the most compelling, immersive, and human-centered brand experiences on the CES show floor. This year, only 30 exhibits were recognized for excellence in storytelling, design, and engagement. We’re proud to see our work recognized and to have set such a strong foundation for our presence at CES moving forward. Thanks to our amazing team members and partners who worked to bring this vision to life. #TeamInsulet

    • No alternative text description for this image
  • Diabetes care is rapidly evolving, and Insulet is proud to be leading the way in innovation.  In a recent Medical Product Outsourcing article, Eric Benjamin, EVP and Chief Operating Officer, shares how consumer health trends are shaping the future of diabetes tech, “Consumers increasingly seek control over their health without added complexity, while wearable technology fuels demand for actionable, non-intrusive data. Understanding daily habits and delivering reliable performance creates exceptional experiences that foster loyalty and confidence.” Read the full article: https://lnkd.in/e3jBBSbP #TeamInsulet

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding

Insulet Corporation 2 total rounds

Last Round

Post IPO debt

US$ 450.0M

See more info on crunchbase